Are clinical trials safe?

Yes. Every study on QualifiedStudies is reviewed and approved by an Institutional Review Board (IRB) and conducted under FDA regulations. Research sites are HIPAA-covered entities, and you can withdraw at any time for any reason.

Do I get paid to participate in a clinical trial?

Most studies offer compensation for your time and travel. The amount varies by study length and visit schedule, and is disclosed up front before you enroll.

Is my health information kept private?

Yes. Your information is encrypted, never sold, and only shared with the specific research site you choose to apply to. Our handling of your data is governed by our Consumer Health Data Privacy Policy; the research sites you're matched with are HIPAA-covered entities.

How do I qualify for a clinical trial?

Take our free 60-second eligibility quiz. Enter your ZIP code, condition, and a few health details, and we'll match you with research sites near you that are actively enrolling participants.

Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)

NCT ID: NCT07486960
Registry status: Recruiting
Study type: Not specified in the registry data
Phase: Phase 2
Sponsor: Merck Sharp & Dohme LLC

Overview

ClinicalTrials.gov lists this study as Recruiting.

Enrollment: 140 participants (Estimated).

What is being studied

No interventions are listed in the registry data.

Who may be eligible

Ages: Not specified in the registry data
Sex: Not specified in the registry data
Healthy volunteers accepted: No

ClinicalTrials.gov lists the following eligibility criteria.

Inclusion Criteria: The main inclusion criteria include but are not limited to the following: * Has a clinical diagnosis of PsA and fulfillment of the Classification Criteria for Psoriatic Arthritis (CASPAR) criteria at Screening, with symptom onset ≥6 months before Screening. * Has a diagnosis of active plaque psoriasis or documented history of plaque psoriasis. * Has history of biologic disease-modifying antirheumatic drug (bDMARD)-naïve or bDMARD-inadequate response/intolerant. Exclusion Criteria: The main exclusion criteria include but are not limited to the following: * Has any arthritis with onset before age 17 years or current diagnosis of inflammatory joint disease other than PsA (such as, but not limited to, rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, myositis, etc), or any other conditions that may, in the judgment of the investigator, interfere with the assessment of PsA. * Has a skin condition diagnosis, other than psoriasis that may, in the judgment of the investigator, interfere with the assessment of psoriasis. * Has a history of cancer (except fully treated nonmelanoma skin cancers or cervical carcinoma in situ after complete surgical removal) and is disease free for \<5 years before Randomization. * Has any active infection. * Has known allergies, hypersensitivity, or intolerance to tulisokibart of its excipients.

Study locations

50 study locations are listed.

Site recruitment status is not specified in the registry data for these locations.

Countries: Canada, Chile, Colombia, Germany, Poland, Spain, Ukraine, United States

Quebec, Canada: 2
Region M. de Santiago, Chile: 6
Atlántico, Colombia: 1
Cundinamarca, Colombia: 1
Valle del Cauca Department, Colombia: 1
Brandenburg, Germany: 1
North Rhine-Westphalia, Germany: 1
Kuyavian-Pomeranian Voivodeship, Poland: 3
Lubusz Voivodeship, Poland: 1
Masovian Voivodeship, Poland: 2
La Coruna, Spain: 1
Kyiv Oblast, Ukraine: 1
Kyivska Oblast, Ukraine: 2
Lviv Oblast, Ukraine: 1
Vinnytsia Oblast, Ukraine: 2
Arizona, United States: 2
California, United States: 3
Florida, United States: 2
Idaho, United States: 1
Maryland, United States: 2
Missouri, United States: 1
Nebraska, United States: 1
New York, United States: 1
North Carolina, United States: 1
Pennsylvania, United States: 2
South Carolina, United States: 1
Texas, United States: 1

Sample of listed locations

Centre Rhumatologie De L'Est ( Site 5201) — Rimouski, Quebec, G5L 8W1, Canada — Site recruitment status not specified in the registry data
Centre de Recherche Musculo-Squelettique ( Site 5202) — Trois-Rivières, Quebec, G9A 3Y2, Canada — Site recruitment status not specified in the registry data
Bradfordhill ( Site 8212) — Santiago, Region M. de Santiago, 8420383, Chile — Site recruitment status not specified in the registry data
CECIM ( Site 8205) — Santiago, Region M. de Santiago, 8331143, Chile — Site recruitment status not specified in the registry data
Centro de Estudios GyC ( Site 8206) — Santiago, Region M. de Santiago, 7500504, Chile — Site recruitment status not specified in the registry data
Centro Internacional de Estudios Clinicos (CIEC) ( Site 8201) — Santiago, Region M. de Santiago, 8420383, Chile — Site recruitment status not specified in the registry data
Clinica Dermacross ( Site 8200) — Santiago, Region M. de Santiago, 7640881, Chile — Site recruitment status not specified in the registry data
Enroll SpA ( Site 8203) — Santiago, Region M. de Santiago, 7500587, Chile — Site recruitment status not specified in the registry data
Clinica de la Costa S.A.S. ( Site 8301) — Barranquilla, Atlántico, 080020, Colombia — Site recruitment status not specified in the registry data
Centro de investigacion en reumatologia y especialidades medicas SAS (CIREEM SAS) ( Site 8306) — Bogota, Cundinamarca, 110221, Colombia — Site recruitment status not specified in the registry data
Fundación Valle del Lili ( Site 8302) — Cali, Valle del Cauca Department, 760032, Colombia — Site recruitment status not specified in the registry data
Rheuma-Research Lausitz ( Site 6409) — Cottbus, Brandenburg, 03042, Germany — Site recruitment status not specified in the registry data
Rheumazentrum Ruhrgebiet ( Site 6400) — Herne, North Rhine-Westphalia, 44649, Germany — Site recruitment status not specified in the registry data
Rheumatologische Schwerpunktpraxis ( Site 6405) — Berlin, 10777, Germany — Site recruitment status not specified in the registry data
HRF II - Hamburger Rheuma Forschungszentrum II MVZ für Rheumatologie und Autoimmunmedizin Hamburg G ( Site 6404) — Hamburg, 20095, Germany — Site recruitment status not specified in the registry data
MICS Centrum Medyczne Bydgoszcz ( Site 6907) — Bydgoszcz, Kuyavian-Pomeranian Voivodeship, 85-065, Poland — Site recruitment status not specified in the registry data
Szpital Uniwersytecki Nr 2 im. dr J. Biziela w Bydgoszczy ( Site 6904) — Bydgoszcz, Kuyavian-Pomeranian Voivodeship, 85-168, Poland — Site recruitment status not specified in the registry data
MICS Centrum Medyczne Torun ( Site 6903) — Torun, Kuyavian-Pomeranian Voivodeship, 87-100, Poland — Site recruitment status not specified in the registry data
Zespół Poradni Specjalistycznych Reumed Filia nr 1 Wallenroda ( Site 6901) — Lublin, Lubusz Voivodeship, 20-607, Poland — Site recruitment status not specified in the registry data
MICS Centrum Medyczne Warszawa ( Site 6905) — Warsaw, Masovian Voivodeship, 00-874, Poland — Site recruitment status not specified in the registry data
Narodowy Instytut Geriatrii Reumatologii i Rehabilitacji im.Prof. El. Reicher-ul.Spartanska 1 ( Site 6906) — Warsaw, Masovian Voivodeship, 02-637, Poland — Site recruitment status not specified in the registry data
CHUS - Hospital Clinico Universitario ( Site 7102) — Santiago de Compostela, La Coruna, 15706, Spain — Site recruitment status not specified in the registry data
Hospital Vall d' Hebron ( Site 7101) — Barcelona, 08029, Spain — Site recruitment status not specified in the registry data
Hospital Viamed Santa Elena ( Site 7105) — Madrid, 28003, Spain — Site recruitment status not specified in the registry data
Hospital Universitario la Fe ( Site 7107) — Valencia, 46026, Spain — Site recruitment status not specified in the registry data

Study details

Start date: April 20, 2026
Primary completion date: August 13, 2027
First posted: March 23, 2026

Source and update information

Source: ClinicalTrials.gov
NCT ID: NCT07486960
Registry last updated: September 14, 2026
QualifiedStudies registry data refreshed: September 21, 2026

View NCT07486960 on ClinicalTrials.gov

Trial information can change. Confirm current study details with the study team or the registry.

About joining clinical research

Find clinical trials you may match with

QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.

Find clinical trials you may match with | Arthritis studies | Clinical trial FAQ